Literature DB >> 1513157

Pulmonary resection for fungal infection in children undergoing bone marrow transplantation.

F M Lupinetti1, D M Behrendt, R H Giller, M E Trigg, P de Alarcon.   

Abstract

Recipients of bone marrow transplants for hematologic malignancies are at risk for a variety of infectious complications. We have reviewed our experience with six patients 2 to 15 years of age who developed significant fungal infections of the lungs before or after bone marrow transplant. No patient was known to have active fungal or bacterial infection at the time bone marrow transplant was performed. In two patients fungal infections were diagnosed before bone marrow transplant, and operations were performed to permit bone marrow transplant under optimal conditions. Four patients had pulmonary mycoses discovered after bone marrow transplant, and underwent operation 12 to 24 days following transplant. Operations consisted of lobectomy (three), multiple unilateral wedge resections (one), staged segmentectomy and contralateral wedge resection (one), and staged bilateral wedge resection (one). Survival following bone marrow transplant was achieved for 6 months and 11 months in patients undergoing lung resection before transplant, and for 24, 30, 39, and 60 days in patients undergoing lung resections after transplant. Bone marrow transplant recipients are at high risk of pulmonary mycoses, and a vigorous search for occult fungal infections should be carried out before transplant. Aggressive operative treatment of fungal infections of the lungs combined with antifungal chemotherapy before transplant may offer the best hope of extended survival.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1513157

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  4 in total

Review 1.  Antifungal prophylaxis during neutropenia and immunodeficiency.

Authors:  O Lortholary; B Dupont
Journal:  Clin Microbiol Rev       Date:  1997-07       Impact factor: 26.132

2.  Prevention of invasive fungal infections during bone marrow transplantation.

Authors:  R Martino; A Altés; A Sureda; S Brunet; A Domingo-Albós
Journal:  Ann Hematol       Date:  1994-09       Impact factor: 3.673

3.  Chemoprophylaxis for pulmonary aspergillosis during intensive chemotherapy.

Authors:  F Cowie; S T Meller; P Cushing; R Pinkerton
Journal:  Arch Dis Child       Date:  1994-02       Impact factor: 3.791

4.  Impact of previous invasive pulmonary aspergillosis on the outcome of allogeneic hematopoietic stem cell transplantation.

Authors:  Ji Yean Lee; Chul Won Jung; Kihyun Kim; Jun Ho Jang
Journal:  Korean J Hematol       Date:  2012-12-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.